Published in Mater Sociomed on January 01, 2011
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32
The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med (2005) 20.72
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med (2003) 13.25
Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med (2009) 12.44
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med (2004) 11.44
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med (2006) 10.58
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med (2010) 8.28
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet (2010) 8.17
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Rosuvastatin in older patients with systolic heart failure. N Engl J Med (2007) 7.55
Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation (2008) 7.11
Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev (2010) 6.49
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med (2009) 5.34
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet (2009) 5.23
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA (2002) 5.19
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet (2011) 4.59
Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med (2009) 4.17
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol (2009) 4.00
Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med (2011) 4.00
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation (2011) 2.87
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet (2010) 2.80
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med (2010) 2.71
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol (2008) 2.66
The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol (2009) 2.61
The association between hospital volume and processes, outcomes, and costs of care for congestive heart failure. Ann Intern Med (2011) 2.40
Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes. Heart (2008) 2.40
Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Circulation (2005) 2.23
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J (2011) 2.14
The national heart failure audit for England and Wales 2008-2009. Heart (2010) 1.85
Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med (2011) 1.80
Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart (2010) 1.74
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation (2010) 1.72
Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev (2004) 1.70
Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart (2009) 1.69
Contribution of exercise echocardiography to the diagnosis of heart failure with preserved ejection fraction (HFpEF). Heart (2010) 1.60
Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J (2009) 1.58
Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol (2008) 1.57
The Heart Failure Revascularisation Trial (HEART). Eur J Heart Fail (2010) 1.57
Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: the RESPOND study. Heart (2011) 1.56
Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction. Heart (2011) 1.41
Rest heart rate and life expectancy. J Am Coll Cardiol (1997) 1.39
Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation (2010) 1.36
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol (1986) 1.33
Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation (2003) 1.32
Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study. Am Heart J (2009) 1.16
Reduced left atrial function on exercise in patients with heart failure and normal ejection fraction. Heart (2010) 1.07
A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study). Heart (2009) 1.00
Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J (2004) 0.94
The decline in heart transplantation in the UK. BMJ (2011) 0.92
Diastolic heart failure: a myth. Curr Opin Cardiol (2006) 0.91
Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT. Heart (2010) 0.90
Age-based exclusions from cardiovascular clinical trials: implications for elderly individuals (and for all of us): comment on "the persistent exclusion of older patients from ongoing clinical trials regarding heart failure". Arch Intern Med (2011) 0.90
Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease. Heart (2010) 0.90
Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study. Heart (2007) 0.89
Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction. Heart (2009) 0.87
Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure. Heart (2011) 0.86
Effects of moderate-to-high intensity resistance training in patients with chronic heart failure. Heart (2009) 0.84
The diagnosis and management of chronic heart failure: review following the publication of the NICE guidelines. Heart (2011) 0.84
Exercise training in heart failure: practical guidance. Heart (2010) 0.80
UK guidelines for referral and assessment of adults for heart transplantation. Heart (2011) 0.78
Revascularization for patients with heart failure. Inconsistencies between theory and practice. Eur J Heart Fail (2011) 0.76
Atrial tachyarrhythmias and cardiac resynchronisation therapy: clinical and therapeutic implications. Heart (2010) 0.76